We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 9,443 results
  1. RNA N6-methyladenosine-modified-binding protein YTHDF1 promotes prostate cancer progression by regulating androgen function-related gene TRIM68

    Purpose

    There is no report about the direct relationship between m6A modification and androgen receptor (AR)-related genes in prostate cancer (PC). We...

    Qihong Nie, **aoyuan Wu, ... Chuance Du in European Journal of Medical Research
    Article Open access 02 December 2023
  2. Selective targeting of the androgen receptor-DNA binding domain by the novel antiandrogen SBF-1 and inhibition of the growth of prostate cancer cells

    Prostate cancers are reliant on androgens for growth and survival. Clinicians and researchers are looking for potent treatments for the resistant...

    Ahmed Elgehama, Lijun Sun, ... Qiang Xu in Investigational New Drugs
    Article 07 January 2021
  3. Dietary fat quality and serum androgen concentrations in middle-aged men

    Background/Objectives

    Average testosterone concentrations in men have declined over the last few decades. The reasons for this are not fully known,...

    Miika M. Wynne-Ellis, Jaakko J. Mursu, ... Jyrki K. Virtanen in European Journal of Clinical Nutrition
    Article Open access 27 October 2023
  4. SC912 inhibits AR-V7 activity in castration-resistant prostate cancer by targeting the androgen receptor N-terminal domain

    Androgen deprivation therapies (ADT) are the mainstay treatments for castration-resistant prostate cancer (CRPC). ADT suppresses the androgen...

    Qianhui Yi, **aojun Han, ... Jian Hui Wu in Oncogene
    Article 26 March 2024
  5. Protein degraders enter the clinic ā€” a new approach to cancer therapy

    Heterobifunctional protein degraders, such as PROteolysis TArgeting Chimera (PROTAC) protein degraders, constitute a novel therapeutic modality that...

    Deborah Chirnomas, Keith R. Hornberger, Craig M. Crews in Nature Reviews Clinical Oncology
    Article 13 February 2023
  6. Protective effects of Allium cepa-fortified feed on testicular function alterations by potassium bromate-induced oxidative damage: an in vivo and in silico approach

    Human infertility can arise from various factors including oxidative stress and endocrine disruptors. This study evaluated the protective effects of Al...

    Charles Obiora Nwonuma, Teslim Alabi Lawal, ... Emmanuel Olorunleke Oludipe in Comparative Clinical Pathology
    Article 18 April 2024
  7. The androgen receptor-targeted proteolysis targeting chimera and other alternative therapeutic choices in overcoming the resistance to androgen deprivation treatment in prostate cancer

    Androgen receptor (AR) plays a vital role in prostate cancer (PCa), including castration-resistant PCa, by retaining AR signalling. Androgen...

    Liuxun Li, Jiangli Xu in Clinical and Translational Oncology
    Article Open access 06 October 2022
  8. Protein translation: biological processes and therapeutic strategies for human diseases

    Protein translation is a tightly regulated cellular process that is essential for gene expression and protein synthesis. The deregulation of this...

    Xuechao Jia, **nyu He, ... Kangdong Liu in Signal Transduction and Targeted Therapy
    Article Open access 23 February 2024
  9. Fundamental concepts of protein therapeutics and spacing in oncology: an updated comprehensive review

    Current treatment regimens in cancer cases cause significant side effects and cannot effectively eradicate the advanced disease. Hence, much effort...

    Bahareh Farasati Far, Maryam Safaei, ... Mohammad Reza Naimi-Jamal in Medical Oncology
    Article 05 May 2023
  10. Impact of structural biology and the protein data bank on us fda new drug approvals of low molecular weight antineoplastic agents 2019ā€“2023

    Open access to three-dimensional atomic-level biostructure information from the Protein Data Bank (PDB) facilitated discovery/development of 100% of...

    Stephen K. Burley, Amy Wu-Wu, ... Steven X. F. Zheng in Oncogene
    Article Open access 17 June 2024
  11. Targeted protein degradation: mechanisms, strategies and application

    Traditional drug discovery mainly focuses on direct regulation of protein activity. The development and application of protein activity modulators,...

    Lin Zhao, Jia Zhao, ... Da Jia in Signal Transduction and Targeted Therapy
    Article Open access 04 April 2022
  12. Retinol and retinol binding protein 4 levels and COVID-19: a Mendelian randomization study

    Background

    The Corona Virus Disease 2019 (COVID-19) pandemic has struck globally. Whether the related proteins of retinoic acid (RA) signaling pathway...

    Haixia Wang, Zhiyun Zhang, ... Shunpeng **ng in BMC Pulmonary Medicine
    Article Open access 26 April 2024
  13. Interleukin-22/Interleukin-22 binding protein axis and oral contraceptive use in polycystic ovary syndrome

    Purpose

    Polycystic ovary syndrome (PCOS) is associated with alterations in gut microbiota. The cytokine interleukin-22 (IL-22) is produced by immune...

    Seren Aksun, Ece Ersal, ... Bulent Okan Yildiz in Endocrine
    Article 04 April 2023
  14. A new role of GRP75-USP1-SIX1 protein complex in driving prostate cancer progression and castration resistance

    Prostate cancer (PC) is the second most common cancer with limited treatment option in males. Although the reactivation of embryonic signals in adult...

    Yuning Liao, Yuan Liu, ... Hongbiao Huang in Oncogene
    Article 02 June 2021
  15. AKT1 regulates UHRF1 protein stability and promotes the resistance to abiraterone in prostate cancer

    Oncogenic activation of PI3K/AKT signaling pathway, together with epigenetic aberrations are the characters of castration-resistant prostate cancer...

    Yongming Fu, Tuoyu Cao, ... **ong Li in Oncogenesis
    Article Open access 02 January 2023
  16. Protein acylation: mechanisms, biological functions and therapeutic targets

    Metabolic reprogramming is involved in the pathogenesis of not only cancers but also neurodegenerative diseases, cardiovascular diseases, and...

    Shuang Shang, **g Liu, Fang Hua in Signal Transduction and Targeted Therapy
    Article Open access 29 December 2022
  17. Targeting a splicing-mediated drug resistance mechanism in prostate cancer by inhibiting transcriptional regulation by PKCĪ²1

    The androgen receptor (AR) is a central driver of aggressive prostate cancer. After initial treatment with androgen receptor signaling inhibitors...

    James E. Melnyk, Veronica Steri, ... Kevan M. Shokat in Oncogene
    Article Open access 27 January 2022
  18. Effects of high-protein diets on the cardiometabolic factors and reproductive hormones of women with polycystic ovary syndrome: a systematic review and meta-analysis

    The optimal dietary regimen for polycystic ovary syndrome (PCOS) has not been identified. High-protein diets (HPDs) are effective for weight control...

    Fang Wang, Pan Dou, ... Peng Ju Liu in Nutrition & Diabetes
    Article Open access 29 February 2024
  19. Sex-related differences of fatty acid-binding protein 4 and leptin levels in atrial fibrillation: an updated review

    Atrial fibrillation (AF) is a prevalent cardiac arrhythmia affecting millions of individuals worldwide and posing significant challenges to...

    Shahab Saidullah, Binish Ayub Ahmad, ... Jahanzeb Malik in International Journal of Arrhythmia
    Article Open access 15 January 2024
  20. Alterations in the balance of sex hormones may affect rat prostatic inflammation and fibrosis, and osteopontin might be involved in this process

    Objective

    This study aimed to investigate the effects of sex hormone imbalance on rat prostatic inflammation and fibrosis and identify the key...

    Ying Cao, Heng Zhang, ... Lei Tang in International Urology and Nephrology
    Article 09 March 2023
Did you find what you were looking for? Share feedback.